The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

Abstract

The urinary tract functions in close proximity to the outside environment, yet must remain free of microbial colonization to avoid disease. The mechanisms for establishing an antimicrobial barrier in this area are not completely understood. Here, we describe the production and function of the cathelicidin antimicrobial peptides LL-37, its precursor hCAP-18 and its ortholog CRAMP in epithelial cells of human and mouse urinary tract, respectively. Bacterial contact with epithelial cells resulted in rapid production and secretion of the respective peptides, and in humans LL-37/hCAP-18 was released into urine. Epithelium-derived cathelicidin substantially contributed to the protection of the urinary tract against infection, as shown using CRAMP-deficient and neutrophil-depleted mice. In addition, clinical E. coli strains that were more resistant to LL-37 caused more severe urinary tract infections than did susceptible strains. Thus, cathelicidin seems to be a key factor in mucosal immunity of the urinary tract.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Immunohistochemical staining of sections from healthy human renal cortical tissue (ad), a piece of human renal cortex incubated in cell culture medium for 24 h (e,f), and a piece infected with uropathogenic E. coli for the same time (g,h).
Figure 2: Cathelicidin LL-37/hCAP-18 in vitro.
Figure 3: Immunofluorescent staining of two sections (one section is shown in ad and the other is shown in eh) from the renal cortex of a NMRI mouse at 24 h of pyelonephritis.
Figure 4: Relevance of epithelium-derived cathelicidin for the protection of the urinary tract against infection.
Figure 5: The course of experimental urinary tract infection in CRAMP-producing Camp+/+ and CRAMP-deficient Camp−/− mice.
Figure 6: Sensitivity of uropathogenic E. coli to synthetic LL-37 peptide expressed as a minimal inhibitory concentration (MIC) of LL-37.

References

  1. 1

    Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389–395 (2002).

    CAS  Article  Google Scholar 

  2. 2

    Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710–720 (2003).

    CAS  Article  Google Scholar 

  3. 3

    Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39–48 (2004).

    Article  Google Scholar 

  4. 4

    Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454–457 (2001).

    CAS  Article  Google Scholar 

  5. 5

    Moser, C. et al. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068–3072 (2002).

    CAS  Article  Google Scholar 

  6. 6

    Valore, E.V. et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633–1642 (1998).

    CAS  Article  Google Scholar 

  7. 7

    Morrison, G., Kilanowski, F., Davidson, D. & Dorin, J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70, 3053–3060 (2002).

    CAS  Article  Google Scholar 

  8. 8

    Zucht, H.D. et al. Human β-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur. J. Med. Res. 3, 315–323 (1998).

    CAS  PubMed  Google Scholar 

  9. 9

    Zaiou, M. & Gallo, R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. 80, 549–561 (2002).

    CAS  Article  Google Scholar 

  10. 10

    Tollin, M. et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24, 523–530 (2003).

    CAS  Article  Google Scholar 

  11. 11

    Agerberth, B. et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160, 283–290 (1999).

    CAS  Article  Google Scholar 

  12. 12

    Gudmundsson, G.H. et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238, 325–332 (1996).

    CAS  Article  Google Scholar 

  13. 13

    Malm, J. et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun. 68, 4297–4302 (2000).

    CAS  Article  Google Scholar 

  14. 14

    Gallo, R.L. et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272, 13088–13093 (1997).

    CAS  Article  Google Scholar 

  15. 15

    Sorensen, O.E. et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951–3959 (2001).

    CAS  Article  Google Scholar 

  16. 16

    Zaiou, M., Nizet, V. & Gallo, R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120, 810–816 (2003).

    CAS  Article  Google Scholar 

  17. 17

    Pestonjamasp, V.K., Huttner, K.H. & Gallo, R.L. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 22, 1643–1650 (2001).

    CAS  Article  Google Scholar 

  18. 18

    Brogden, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250 (2005).

    CAS  Article  Google Scholar 

  19. 19

    Scott, M.G., Davidson, D.J., Gold, M.R., Bowdish, D. & Hancock, R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883–3891 (2002).

    CAS  Article  Google Scholar 

  20. 20

    Yang, D., Biragyn, A., Kwak, L.W. & Oppenheim, J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291–296 (2002).

    CAS  Article  Google Scholar 

  21. 21

    Bowdish, D.M., Davidson, D.J. & Hancock, R.E. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6, 35–51 (2005).

    CAS  Article  Google Scholar 

  22. 22

    Turner, J., Cho, Y., Dinh, N.N., Waring, A.J. & Lehrer, R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206–2214 (1998).

    CAS  Article  Google Scholar 

  23. 23

    Faurschou, M. & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317–1327 (2003).

    CAS  Article  Google Scholar 

  24. 24

    Hase, K., Eckmann, L., Leopard, J.D., Varki, N. & Kagnoff, M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70, 953–963 (2002).

    CAS  Article  Google Scholar 

  25. 25

    Norden, C.W., Green, G.M. & Kass, E.H. Antibacterial mechanisms of the urinary bladder. J. Clin. Invest. 47, 2689–2700 (1968).

    CAS  Article  Google Scholar 

  26. 26

    Justice, S.S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 101, 1333–1338 (2004).

    CAS  Article  Google Scholar 

  27. 27

    Gordon, D.M. & Riley, M.A. A theoretical and experimental analysis of bacterial growth in the bladder. Mol. Microbiol. 6, 555–562 (1992).

    CAS  Article  Google Scholar 

  28. 28

    Cox, C.E. & Hinman, F., Jr. Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. J. Urol. 86, 739–748 (1961).

    CAS  Article  Google Scholar 

  29. 29

    Mulvey, M.A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497 (1998).

    CAS  Article  Google Scholar 

  30. 30

    Bates, J.M. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791–797 (2004).

    CAS  Article  Google Scholar 

  31. 31

    Fliedner, M., Mehls, O., Rauterberg, E.W. & Ritz, E. Urinary sIgA in children with urinary tract infection. J. Pediatr. 109, 416–421 (1986).

    CAS  Article  Google Scholar 

  32. 32

    Abrink, M., Larsson, E., Gobl, A. & Hellman, L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int. 57, 2004–2010 (2000).

    CAS  Article  Google Scholar 

  33. 33

    Islam, D. et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7, 180–185 (2001).

    CAS  Article  Google Scholar 

  34. 34

    Bergman, P. et al. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7, 1009–1017 (2005).

    CAS  Article  Google Scholar 

  35. 35

    Johansson, J., Gudmundsson, G.H., Rottenberg, M.E., Berndt, K.D. & Agerberth, B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273, 3718–3724 (1998).

    CAS  Article  Google Scholar 

  36. 36

    Sorensen, O., Arnljots, K., Cowland, J.B., Bainton, D.F. & Borregaard, N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796–2803 (1997).

    CAS  PubMed  Google Scholar 

  37. 37

    Dorschner, R.A. et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20, 35–42 (2006).

    CAS  Article  Google Scholar 

  38. 38

    Yan, H. & Hancock, R.E. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45, 1558–1560 (2001).

    CAS  Article  Google Scholar 

  39. 39

    Braff, M.H., Zaiou, M., Fierer, J., Nizet, V. & Gallo, R.L. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73, 6771–6781 (2005).

    CAS  Article  Google Scholar 

  40. 40

    Yoshio, H. et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr. Res. 53, 211–216 (2003).

    CAS  Article  Google Scholar 

  41. 41

    Todd, J.H., McMartin, K.E. & Sens, D.A. Enzymatic isolation and serum-free culture of human renal cells. in Human cell culture protocols (ed. Jones, G.E.) 431–436 (Humana Press, Totowa, 1996).

    Google Scholar 

  42. 42

    Rossi, M.R. et al. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ. Health Perspect. 109, 801–808 (2001).

    CAS  Article  Google Scholar 

  43. 43

    Khalil, A. et al. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J. Urol. 158, 1576–1580 (1997).

    CAS  Article  Google Scholar 

  44. 44

    Chromek, M. et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring. Pediatr. Res. 53, 698–705 (2003).

    CAS  Article  Google Scholar 

  45. 45

    Black, C.A. et al. Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun. 66, 1273–1275 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Z. Fehervízyová and T. Baltesová for help collecting urine samples, M. Lindh for technical assistance and G. Kronvall for help with single-strain regression analysis. This work was supported by ALF Project Funding, The Swedish Society of Medicine, The Swedish Association of Kidney Patients, funds from the Karolinska Institute, Magn. Bergvalls Foundation, Capio Foundation, The Swedish Research Council (04X-2887, 06X-11217), The Swedish Foundation for International Cooperation in Research and Higher Education (STINT), and the Knut and Alice Wallenberg Foundation.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Annelie Brauner.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

LL-37/hCAP-18 levels in urine of 28 healthy children and in 29 children with acute urinary tract infection. (PDF 77 kb)

Supplementary Fig. 2

Human LL-37/hCAP-18 mRNA and protein levels in noninfected renal and uroepithelial cells and tissues. (PDF 27 kb)

Supplementary Methods (PDF 71 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chromek, M., Slamová, Z., Bergman, P. et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12, 636–641 (2006). https://doi.org/10.1038/nm1407

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing